Labrador, Baby Boy .

HRN: 28-75-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CEFUROXIME 750MG (VIAL)
03/27/2026
04/03/2026
IV
250mg
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: